SCHEMBL6766013

SCHEMBL6766013

CCOC(=O)C(N)CC(=O)N(c1cc(C)c(NC(=O)CNc2ccc(C#N)cc2)cc1C)C(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 13/20 0.42
MAPT P10636 9/20 0.42
GAA P10253 6/20 0.42
HSP90AA1 P07900 1/20 0.42
HSP90AB1 P08238 1/20 0.42
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
MAPK1 P28482 1/20 0.39
PKM P14618 1/20 0.38
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
PSMB5 P28074 1/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
LMNA P02545 3/20 0.35
KDM4E B2RXH2 2/20 0.35
HTT P42858 1/20 0.35
IDO1 P14902 1/20 0.34
RORC P51449 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6574024 0.87 ALDH1A1 (0.43) ALDH1A1MAPTGAAHSP90AA1HSP90AB1
SCHEMBL6762132 0.86 ALDH1A1 (0.40) ALDH1A1MAPTGAAHSP90AA1HSP90AB1
SCHEMBL6574412 0.84 ALDH1A1 (0.42) ALDH1A1MAPTGAAHSP90AA1HSP90AB1
SCHEMBL6766036 0.77 ITGB3 (0.42) ALDH1A1MAPTGAAHSP90AA1HSP90AB1
SCHEMBL6569900 0.74 ITGB3 (0.41) ALDH1A1MAPTGAAHSP90AA1HSP90AB1
SCHEMBL6572891 0.73 IDO1 (0.43) ALDH1A1PSMB5SMN1; SMN2LMNAIDO1
SCHEMBL6573948 0.72 ALDH1A1 (0.47) ALDH1A1MAPTGAAHSP90AA1HSP90AB1
SCHEMBL6571792 0.72 PSMB5 (0.38) ALDH1A1MAPTGAAKMT2AMEN1
SCHEMBL6571971 0.72 ALDH1A1 (0.39) ALDH1A1MAPTGAAHSP90AA1HSP90AB1
SCHEMBL8360714 0.71 ITGB3 (0.45) ALDH1A1MAPTGAAHSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040248897-A1 Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248897-A1 Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions NAT1, CYP3A5, CYP3A7 ALDH1A1 669/4885MAPT 449/4885GAA 454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.